Tus kws kho mob
QP52-23 MHCP Pharmacy Benefit Exclusion for Iheezo™, Omisirge®, and Qalsody™
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 14, 2023
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 1421 - 1430 ntawm 3685
Tus kws kho mob
QP53-23 Commercial Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective August 1, 2023
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 14, 2023
Tus kws kho mob
Furoscix® (furosemide) - Medicaid
Prior Authorization, Quantity Limit
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 01, 2024
Tus kws kho mob
Antidepressant - Medicaid
Quantity Limit
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 01, 2025
Tus kws kho mob
QP48-23 Update for New to Market Medical Drugs: delandistrogene moxeparvovec and epcoritamab
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 14, 2023
Tus kws kho mob
QP49-23 Register for Webinar | Trauma-Informed Care 101 | Thursday, June 29, 5-6:30 pm
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 14, 2023
Tus kws kho mob
QP50-23 Fetal Alcohol Syndrome Education Opportunity
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 14, 2023
Tus kws kho mob
P50-23 eviCore Healthcare Specialty Utilization Management (UM) Program: Medical Oncology Drug Prior Authorization Updates
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 03, 2023
Tus kws kho mob
P51-23 Medical Policy Updates: Coupe Health and Self-Funded Benefit Plans managed by Blue Cross and Blue Shield of Alabama
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 03, 2023
Tus kws kho mob
QP59-23 Provider Implicit Bias Training
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 28, 2023